Compare UNB & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UNB | VANI |
|---|---|---|
| Founded | 1891 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.1M | 95.8M |
| IPO Year | 1999 | 2014 |
| Metric | UNB | VANI |
|---|---|---|
| Price | $23.63 | $0.97 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 4.9K | ★ 189.8K |
| Earning Date | 04-15-2026 | 03-26-2026 |
| Dividend Yield | ★ 6.19% | N/A |
| EPS Growth | ★ 25.52 | N/A |
| EPS | ★ 2.41 | N/A |
| Revenue | N/A | ★ $4,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $9.65 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $20.65 | $0.91 |
| 52 Week High | $34.85 | $1.92 |
| Indicator | UNB | VANI |
|---|---|---|
| Relative Strength Index (RSI) | 50.44 | 27.67 |
| Support Level | $23.54 | N/A |
| Resistance Level | $25.02 | $1.26 |
| Average True Range (ATR) | 0.65 | 0.07 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 67.11 | 2.15 |
Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The company provides retail banking services to individuals and commercial banking services to small and medium-sized corporations, partnerships, and sole proprietorships, as well as nonprofit organizations, local municipalities, and school districts within its market area. In addition, it also offers fiduciary and asset management services through its Asset Management Group.
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.